Brief: Biosynex Obtained Approval In 4 EU Countries For Its SARS-COV-2 Antigenic Self-Tests

Biosynex SA

31/03/2021 18:14

March 31 (Reuters) - BIOSYNEX SA  ALBIO.PA :
    * TO ACCELERATE DEPLOYMENT OF ITS SARS-COV-2 ANTIGENIC
SELF-TESTS
IN EUROPE FOLLOWING APPROVALS IN 4 EUROPEAN UNION COUNTRIES
    * IT HAS OBTAINED DEROGATION IN 4 EUROPEAN COUNTRIES
(GERMANY,
BELGIUM, FRANCE AND THE NETHERLANDS) FOR ITS SARS-COV-2
ANTIGENIC SELF-TESTS CURRENTLY UNDERGOING CE MARKING

Source text for Eikon:  ID:nBw51FnNCa 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))